www.fiercehealthcare.com Open in urlscan Pro
104.16.241.114  Public Scan

Submitted URL: https://qtx.omeclk.com/portal/wts/ucmcmQ6ej%7C2bbcDxcEsxecocfxqTaEwHYzqR%7CYeXp
Effective URL: https://www.fiercehealthcare.com/finance/walgreens-sells-remaining-stake-option-care-health-330m-latest-divestiture?utm_medium=em...
Submission: On June 12 via manual from US — Scanned from DE

Form analysis 2 forms found in the DOM

GET /search-results

<form action="/search-results" method="get">
  <fieldset class="d-flex align-items-center position-relative input-search"><input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100"><button class="search-submit d-flex align-items-center" id="search-submit"
      type="submit"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
        <path fill="currentColor"
          d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
        </path>
      </svg></button><input type="hidden" placeholder="Search" name="dns" value="fiercehealthcare_com,fiercebiotech_com,fiercepharma_com"></fieldset>
</form>

GET /search-results

<form class="w-100" action="/search-results" method="get">
  <fieldset class="d-flex justify-content-between position-relative input-search"><input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100"><button class="search-submit d-flex align-items-center" id="search-submit"
      type="submit"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
        <path fill="currentColor"
          d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
        </path>
      </svg></button></fieldset>
</form>

Text Content

 * Fierce Pharma
 * Fierce Biotech
 * Fierce Healthcare
 * Fierce Life Sciences Events

 * Advertise
 * About Us



 * Providers
   
   * Hospitals
   * Practices
   * Retail
 * Health Tech
   
   * AI and Machine Learning
   * Digital Health
   * Telehealth
 * Finance
 * Payers
 * Regulatory
 * Special Reports
 * Podcasts

 * Resources
   
   * Webinars
   * Fierce Events
   * Industry Events
   * Podcasts
   * Whitepapers
 * Events
   
   
 * Subscribe

Subscribe

 * Providers
   
   * Hospitals
   * Practices
   * Retail
 * Health Tech
   
   * AI and Machine Learning
   * Digital Health
   * Telehealth
 * Finance
 * Payers
 * Regulatory
 * Special Reports
 * Podcasts

 * Resources
   
   * Webinars
   * Fierce Events
   * Industry Events
   * Podcasts
   * Whitepapers
 * Events
   
   
 * Subscribe

 * Fierce Pharma
 * Fierce Biotech
 * Fierce Healthcare
 * Fierce Life Sciences Events

 * Advertise
 * About Us




Finance


WALGREENS SELLS REMAINING STAKE IN OPTION CARE HEALTH FOR $330M IN LATEST
DIVESTITURE MOVE

By Heather LandiJun 9, 2023 12:00pm
WalgreensOption Care HealthPrimary CareOptum
In December, Walgreens sold shares of drug distributor AmerisourceBergen
Corporation for proceeds of about $1 billion. Walgreens said at the time it
planned to use the proceeds for debt paydown and to fund VillageMD's acquisition
of Summit Health-CityMD. (Walgreens)

Walgreens Boots Alliance sold its remaining stake in post-acute care and
infusion services company Option Care Health for $330 million.




The drugstore chain announced Thursday it sold 10.8 million shares of Option
Care Health and plans to use the proceeds primarily for debt paydown, continued
support of the company's strategic priorities and to help fund its
healthcare-focused business initiatives, according to a press release.




"The transaction is another decisive action WBA is taking to unlock value and
further simplify the company’s portfolio," the company said.

Back in March, Walgreens cut its stake in Option Care Health when it sold 15.5
million shares at $30.75 per share. The transaction reduced Walgreen's ownership
in the company, formerly known as Walgreens Infusion Services, from 14% to 6%,
according to a Walgreens news release. 

The pharmacy retail giant has been reducing its stake in other companies in the
past two years as it shifts its focus to providing healthcare services.


RELATED

Walgreens plots 'aggressive' strategy to build out healthcare services, CEO Roz
Brewer says


Last month, Walgreens sold shares of AmerisourceBergen Corporation, a drug
distribution company, for proceeds of approximately $694 million. That came on
the heels of another sale of the distributor's stock in December that netted
Walgreens about $1 billion. Walgreens said at the time it planned to use the
proceeds for debt paydown and to fund VillageMD's acquisition of Summit
Health-CityMD. Those transactions reduced Walgreens' stake in AmerisourceBergen
to less than 20%.

Walgreens aims to be a point of entry for consumers for healthcare services
ranging from urgent care to specialty care and even in-home health. Back in
November at the HLTH 2022 conference, Walgreens Boots Alliance CEO Rosalind
"Roz" Brewer said dispensing of pharmaceuticals was not going to be
Walgreens' long-term growth avenue.

"For us, we have been very aggressive and will continue to be to set up a
healthcare continuum and deliver healthcare services through a brand that
everyone knows and trusts," she told the HLTH audience.

The company has made a number of high-profile acquisitions to pursue this
strategy.

Featured Event

SHOWCASING LEADERSHIP AND INNOVATION IN THE PAYER INDUSTRY

November 2-3, 2023

Austin, TX

Learn More

Walgreen's VillageMD bought the urgent and primary care chain, Summit
Health-CityMD, in a deal worth close to $9 billion. The VillageMD-Summit Health
deal will expand Walgreen's reach into primary, specialty and urgent care. The
transaction creates one of the largest independent provider groups in the U.S.,
the organizations said. Combined, VillageMD and Summit Health will operate more
than 680 provider locations in 26 markets. 

Walgreens said it would invest $3.5 billion through an even mix of debt and
equity to support the acquisition. The company will remain the largest and
consolidating shareholder of VillageMD with about a 53% stake.

That transaction also includes an investment from Cigna’s health services
business Evernorth.

The drugstore chain also expects to close its acquisition of post-acute and home
care company CareCentrix in the third quarter of fiscal 2023. CareCentrix
currently manages care for more than 19 million members through over 7,400
provider locations. The company announced plans last year to snap up its
remaining stake in CareCentrix for approximately $392 million.

It also closed its acquisition of specialty pharmacy Shields Health Solutions in
December.


RELATED

Home health bidding wars heat up: Optum makes $3B unsolicited offer for Amedisys

There has been a frenzy of M&A activity in the past two years as major retailers
like CVS, Walgreens and Amazon are ramping up their focus on providing medical
services to gain bigger footholds in the healthcare market.

Drugstore rival CVS Health picked up home health and technology services company
Signify Health in an $8 billion deal and also recently acquired Medicare-focused
primary care provider Oak Street Health for $10.6 billion. Amazon bought primary
care provider One Medical for $3.9 billion.

Insurers also have been active in M&A to get a bigger piece of the healthcare
pie. UnitedHealth Group's Optum unit has been buying up physician practices

And now the home health bidding wars are heating up as well with Option Care
Health as one of the big players. The company is trying to buy home health and
hospice firm Amedisys for more than $3 billion.

But it now faces major competition, as earlier this week Optum made
an unsolicited all-cash buyout offer for Amedisys. 

ProvidersPracticesRetailFinanceUnitedHealth GroupinfusionAmedisys

Our Newsletter






ATTEND EVENTS

22 Jun


FIERCE LEADERS IN LIFE SCIENCES FORUM

Free Virtual Event
18-19 Jul


PHARMA PR & COMMUNICATIONS SUMMIT

July 18-19, 2023 | Jersey City, NJ
11-14 Sep


DIGITAL PHARMA EAST

Philadelphia, PA


RELATED ARTICLES

Simple HealthKit inks deal with Walmart to expand access to at-home tests
Jun 12, 2023 09:00am
Tech company Artera launches solution to help health systems manage all those
texts, emails to patients
Jun 12, 2023 08:30am
Oncologist Shares 7 Things To Know About Your Cancer Support Program
Jun 12, 2023 08:00am
Not covering emerging Alzheimer's drugs could cost Medicare billions: study
Jun 12, 2023 08:00am
See more articles
 * Connect
   
   * The Team
   * Advertise
 * Join Us
   
   * Newsletters
   * Resources
   * RSS Feeds
   * Editorial Advisory Council
 * Our Brands
   
   * Fierce Pharma
   * Fierce Biotech
   * Fierce Healthcare
 * Our Events
   
   * Life Sciences Events

©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy



Close

In order to deliver a personalized and enhanced site navigation, we store
information on how you use the site. By continuing to use this site and access
it's features, you are consenting to our use of cookies. For more information,
please see the Questex Privacy Policy.